Reuters logo
BRIEF-Immunomedics awarded additional intellectual property protection for IMMU-140, an antibody-drug conjugate with dual-therapeutic potential
December 22, 2016 / 12:18 PM / a year ago

BRIEF-Immunomedics awarded additional intellectual property protection for IMMU-140, an antibody-drug conjugate with dual-therapeutic potential

Dec 22 (Reuters) - Immunomedics Inc

* Immunomedics awarded additional intellectual property protection for IMMU-140, an antibody-drug conjugate with dual-therapeutic potential

* Immunomedics says issued patent provides additional coverage for IMMU-140, third antibody-drug conjugate (ADC) based on co’s SN-38 platform technology Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below